The cell-surface tyrosine kinase KIT receptor is vital to the function and survival of ICCs, with 85% of GIST occurring due to mutually exclusive activating mutations of KIT (CD-117) or platelet-derived growth factor receptor alpha (PDGFRA) [5,6]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.